259 related articles for article (PubMed ID: 27462161)
1. Erratum: Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum].
Ther Clin Risk Manag; 2016; 12():1083. PubMed ID: 27462161
[TBL] [Abstract][Full Text] [Related]
2. Erratum: Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease [Corrigendum].
Drug Des Devel Ther; 2015; 9():5213. PubMed ID: 26388688
[TBL] [Abstract][Full Text] [Related]
3. Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases.
Cox TM
Curr Opin Investig Drugs; 2010 Oct; 11(10):1169-81. PubMed ID: 20872320
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum.
J Indian Soc Periodontol; 2021; 25(3):270. PubMed ID: 34158698
[TBL] [Abstract][Full Text] [Related]
6. Profile of eliglustat tartrate in the management of Gaucher disease.
Sechi A; Dardis A; Bembi B
Ther Clin Risk Manag; 2016; 12():53-8. PubMed ID: 26811686
[TBL] [Abstract][Full Text] [Related]
7. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():1365. PubMed ID: 26229429
[TBL] [Abstract][Full Text] [Related]
8. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():453. PubMed ID: 25834381
[TBL] [Abstract][Full Text] [Related]
9. Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease.
Bennett LL; Turcotte K
Drug Des Devel Ther; 2015; 9():4639-47. PubMed ID: 26345314
[TBL] [Abstract][Full Text] [Related]
10. Case report of unexpected gastrointestinal involvement in type 1 Gaucher disease: comparison of eliglustat tartrate treatment and enzyme replacement therapy.
Kim YM; Shin DH; Park SB; Cheon CK; Yoo HW
BMC Med Genet; 2017 May; 18(1):55. PubMed ID: 28506293
[TBL] [Abstract][Full Text] [Related]
11. Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.
Belmatoug N; Di Rocco M; Fraga C; Giraldo P; Hughes D; Lukina E; Maison-Blanche P; Merkel M; Niederau C; PlÓ§ckinger U; Richter J; Stulnig TM; Vom Dahl S; Cox TM
Eur J Intern Med; 2017 Jan; 37():25-32. PubMed ID: 27522145
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.
Balwani M; Burrow TA; Charrow J; Goker-Alpan O; Kaplan P; Kishnani PS; Mistry P; Ruskin J; Weinreb N
Mol Genet Metab; 2016 Feb; 117(2):95-103. PubMed ID: 26387627
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum].
J Pain Res; 2018; 11():213. PubMed ID: 29406534
[TBL] [Abstract][Full Text] [Related]
14. Eliglustat tartrate, a prototypic glucosylceramide synthase inhibitor.
Shayman JA
Expert Rev Endocrinol Metab; 2013 Nov; 8(6):491-504. PubMed ID: 30736134
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].
Breast Cancer (Dove Med Press); 2018; 10():51. PubMed ID: 29589598
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Amino acid management of Parkinson's disease: a case study [Corrigendum].
Int J Gen Med; 2016; 9():205. PubMed ID: 27354822
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum].
Clin Interv Aging; 2016; 11():775. PubMed ID: 27358559
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Electronic health records and improved nursing management of chronic obstructive pulmonary disease [Corrigendum].
Patient Prefer Adherence; 2015; 9():607. PubMed ID: 25995621
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2019; 14():243. PubMed ID: 30718949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
